Abstract:OBJECTIVE:To study the clinical effects of endovascular reconstruction versus bypass surgery for TASC II(trans-atlantic inter-society consensus II) C/D femoropopliteal artery lesion resulted from arteriosclerosis obliterans.METHODS:One hundred and three patients(119 limbs)accepted bypass surgery or endovascular therapy for TASCII C/D femoropopliteal artery lesion between January 2002 and December 2012 at our institution were retrospectively assessed.All the patients were diagnosed with arteriosclerosis obliterins, and all their Rutherford classifications were from 2 to 5 degrees.Among them there were 71 limbs treated by endovascular reconstruction and the other 48 limbs were treated with bypass surgery.We evaluated the short term clinical effect according to the condition when patients left the hospital, and evaluated the long term clinical effect according to the results of the patients' latest follow-up in 2014. Their clinical data before treatment, complication rates, death rates, hospital stays, short term and long term effects, reoperation rates, 1 to 10 years primary and secondary accumulative patency rates and limb salvage rates were compared.RESULTS:There was no significant difference between the bypass group and the endovascular group on the mean age and ankle brachial index before treatment [(67.1 ± 7.1) years(51 to 80 years) vs. (68.0 ± 9.4) years (49 to 91 years), P=0.561;(0.41 ± 0.23) vs. (0.40 ± 0.26), P=0.928]. There were more TASCII D patients in the bypass group than those in the endovascular group (P<0.001), and the rutherford classification was higher in the endovascular group than that in the bypass group. The difference in the mean follow-up between the bypass group and the endovascular group was not significant [(41.7 ± 23.6) months vs. (59.5 ± 41.6) months, P=0.065]. Five peri-operative complication cases occurred in the bypass group, including 2 cases of acute thrombosis,1 case of infection and 2 cases of heart failure, and only 1 complication case occurred in the endovascular group that was heart failure.The complication rate was higher in the bypass group than that in the endovascular group [10.4% vs. 1.4%, P=0.039]. And there was no death in both the groups.Compared with the endovascular group, the bypass group had a longer hospital stays [(13.2 ± 4.7) d vs.(6.5 ± 3.1) d, P<0.001], a higher reoperation rate (58.3% vs.31.0%,P=0.003), a better short term, obvious, and effective rate (25.0% vs. 9.9%, P=0.027), a worse long term deterioration rate (37.5% vs. 18.3%, P=0.019) and higher 1 to 10 years primary and secondary accumulative patency rates(P=0.001, P=0.001).There was no significant difference between the two groups on the increase of ankle brachial index [(0.34 ± .28) vs. (0.31 ± 0.23), P=0.371], and short term and long term total effective rates (89.6% vs.84.5%, P=0.426; 45.8% vs. 56.3%, P=0.260), and limb salvage rate (83.3% vs.94.4%, P=0.051).CONCLUSION:Endovascular therapy is a safe, effective and minimally invasive therapy for TASCII C/D femoropopliteal artery lesion resulted from arteriosclerosis obliterans.

Mid-Term Outcomes Of Endovascular Treatment And Risk Factors For Recurrence In Patients With Trans-Atlantic-Inter-Society Ii C/D Femoropopliteal Lesions

Endovascular Interventions for Transatlantic Intersociety Consensus Ii C and D Femoropopliteal Lesions

Open and Endovascular Treatment of Trans-Atlantic Inter-Society Consensus II D Aortoiliac Occlusive Lesions: What Determines the Rate of Restenosis?

The Efficacy Analysis of Endovascular Intervention Therapy for Transatlantic Inter Society Consensus Type C and Type D Femoropopliteal Arteriosclerosis Lesion

Endovascular therapy for Transatlantic Inter Society Consensus Ⅱ type D peripheral arterial diseases

Mid-term clinical results and predictors of vessel patency after stenting for TASC Ⅱ C and D femoropopliteal arterial lesions

Acute and Long-term Outcome of Endovascular Therapy for Aortoiliac Occlusive Lesions Stratified According to the TASC Classification: A Single-Center Experience

Outcomes of Endovascular Reconstructive Techniques in Trans-Atlantic Inter-Society Consensus II C-D Aortoiliac Lesions

The Midterm Outcomes of Endovascular Therapy for Femoropopliteal Lesions via Drug-Coated Balloon, Directional Atherectomy and Bare Metal Stent Angioplasty

[Comparison of the Clinical Efficacy of Endovascular Reconstruction Versus Bypass Surgery for Transatlantic Inter-Society Consensus II C/D Femoropopliteal Artery Lesion Resulted from Arteriosclerosis Obliterans].

Outcomes of Endovascular Treatment for Patients with TASC II D Femoropopliteal Occlusive Disease: a Single Center Study

Treatment extent of femoropopliteal disease and clinical outcomes following endovascular therapy

The clinical efficacy of endovascular intervention for femoropopliteal arteriosclerosis

Endovascular treatment for symptomatic stent failures in long-segment chronic total occlusion of femoropopliteal arteries.

Long-term Results of Endovascular Reconstruction for Aortoiliac Occlusive Disease.

Three‐year outcomes of contemporary endovascular treatment in over 25‐cm femoropopliteal artery disease from a retrospective multicenter registry: A retrospective observational study

Endovascular recanalization of infra-popliteal TASC C and TASC D lesions in patients with critical limb-threatening ischemia: a single-center experience

Efficacy of endovascular treatment of Trans-Atlantic Inter-Society Consensus D aortoiliac occlusive disease

Long-term results of extensive aortoiliac occlusive disease (EAIOD) treated by endovascular therapy and risk factors for loss of primary patency

Comparison of the clinical effects of endovascular therapy and bypass surgery for Trans-Atlantic Inter-Society ConsensusⅡC/D femoropopliteal artery disease

Long Term Results of Endovascular Therapy and Aortofemoral Bypass for Transatlantic Inter-Society Type C and D Aortoiliac Occlusive Disease